Liam Sweeney at Digital Healthcare uses the company’s OptoMize iP software to check for diabetic maculopathy, a common cause of loss of vision in patients with diabetes.
A major community eye screening programme to monitor the sight of 12,000 diabetes patients across Central Lancashire over a 12 month period has scored a world first in using secure messaging telemedicine to successfully transfer patient information between opticians, hospitals and a screening administration centre within the PCTs. The diabetic retinopathy screening programme is using OptoMize, an innovative software product combining digital images of the retina with an electronic patient administration system, to electronically transfer screening results between a network of different computers. OptoMize iP was developed by Digital Healthcare, a Cambridge company that is the UK’s leading supplier of software for diabetic retinal screening programmes and ophthalmology.
The screening programme involves Preston and Chorley & South Ribble Primary Care Trusts, the Royal Preston Hospital and Chorley District Hospital as well as 17 optician practices across Preston, Chorley, Leyland and surrounding villages. It is encouraging all diabetes patients over 12 years old to have a digital photographic screen of their eyes which can detect the early signs of retinopathy, a disease of the retina that is the single largest cause of blindness in the UK.
Digital Healthcare’s OptoMize iP software has been installed on 48 computers in a variety of locations across Central Lancashire so that patients can choose to be screened by an accredited optometrist at their local optician or at an eye clinic in a hospital. The results are transferred electronically between the computers on the same network.
Barely scratching the surface: A new way to make robust membranes
13.12.2018 | DOE/Argonne National Laboratory
Topological material switched off and on for the first time
11.12.2018 | ARC Centre of Excellence in Future Low-Energy Electronics Technologies
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy